(VIANEWS) – The NASDAQ ended the session with 10x Genomics (TXG) rising 5.35% to $146.22 on Tuesday while NASDAQ Composite jumped 2.29% to $15,324.56.
Today’s last reported volume for 10x Genomics is 506648, 26.38% below its average volume of 688217.
10x Genomics’s last close was $138.80, 33.59% under its 52-week high of $208.99.
10x Genomics’s Sales
10x Genomics’s sales growth is 78.1% for the present quarter and 33.2% for the next. The company’s growth estimates for the present quarter and the next is 70.8% and 97.2%, respectively.
10x Genomics’s Revenue
Year-on-year quarterly revenue growth grew by 170%, now sitting on 405.7M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
10x Genomics’s stock is considered to be oversold (<=20).
10x Genomics’s Stock Yearly Top and Bottom Value
10x Genomics’s stock is valued at $146.22 at 18:43 EST, way below its 52-week high of $208.99 and way above its 52-week low of $128.15.
10x Genomics’s Moving Average
10x Genomics’s value is below its 50-day moving average of $155.93 and way below its 200-day moving average of $170.12.
More news about 10x Genomics (TXG).